Browsing Tag
Vaxart
3 posts
Vaxart advances oral vaccine platform with positive maternal and infant data from norovirus study
Find out how Vaxart advanced its oral vaccine platform with positive norovirus data showing maternal immune responses and antibody transfer to infants.
Dynavax (NASDAQ: DVAX) targets 60% U.S. hepatitis B market share by 2030 amid COVID vaccine deal, $100m buyback
Dynavax targets 60% of U.S. hepatitis B vaccine market by 2030, expands COVID-19 pipeline, and authorizes $100M buyback. Read what this signals for investors.
Vaxart’s oral COVID-19 vaccine gains momentum with DSMB approval
Vaxart, Inc., a clinical-stage biotechnology company headquartered in South San Francisco, has announced a critical advancement in its…